Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis
We evaluated the effect of adjunctive intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome patients using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% (risk ratio 0.46, 95% confidence intervals 0.26-0.83, p=0.010) w...
Príomhchruthaitheoirí: | Parks, T, Wilson, C, Curtis, N, Norrby-Teglund, A, S, S |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
Oxford University Press
2018
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis
de réir: Parks, T, et al.
Foilsithe / Cruthaithe: (2018) -
Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
de réir: Delphine Laho, et al.
Foilsithe / Cruthaithe: (2021-08-01) -
Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome
de réir: Parham Sendi, et al.
Foilsithe / Cruthaithe: (2009-02-01) -
Streptococcal toxic shock syndrome in an adolescent
de réir: N. A. Ryzhakova, et al.
Foilsithe / Cruthaithe: (2022-04-01) -
Superantigens and Streptococcal Toxic Shock Syndrome
de réir: Thomas Proft, et al.
Foilsithe / Cruthaithe: (2003-10-01)